期刊文献+

七种抗精神病药对精神分裂症患者维持治疗一年的有效性及安全性研究 被引量:11

Maintenance treatment effectiveness of seven antipsychotic drugs in schizophrenic patients: a 1-year follow-up study
分享 导出
摘要 目的比较氯丙嗪、舒必利、氯氮平、利培酮、奥氮平、奎硫平、阿立哌唑7种抗精神病药对精神分裂症患者1年维持治疗的有效性及安全性。方法对服用7种药物之一、病程≤5年稳定期的1227例精神分裂症患者给予1年的维持治疗,以治疗中断率、中断前治疗时间并结合临床疗效评价抗精神病药的总体有效性,采用不良事件和实验室检查评价安全性,每间隔3个月评估1次。结果随访1年,1227例患者中共有541例(44.1%)患者中断治疗。7个药物组间治疗中断率(P=0.283)及中断前治疗时间(P=0.400)的差异均无统计学意义(P〉0.05);495例(40.3%)患者完成1年随访并达到临床痊愈标准,临床痊愈率在7个药物组间的差异无统计学意义(χ^2=3.211,P〉0.05)。7个药物组总的不良反应发生率(88.3%-95.6%)的差异无统计学意义(χ^2=8.345,P〉0.05),但镇静作用(χ^2=100.836)、锥体外系不良反应(χ^2=68.074)、月经紊乱(χ^2=71.295)及体质量增加(χ^2=13.527)等不良反应在不同药物问的差别有统计学意义(P〈0.01和0.05)。结论7种抗精神病药治疗精神分裂症患者1年的临床疗效相当,但药物的不良反应各异。 Objective To compare the effectiveness of seven antipsychotic agents including chlorpromazine, sulpiride, clozapine, risperidone, olanzapine, quetiapine, and aripiprazole to schizophrenia after 1 year maintenance treatment, nethods A total of 1227 patients suffering from schizophrenia for less than 5 years who took one of the seven medications as maintenance treatment were recruited at 10 China sites, and followed up to 1 year. The subjects were assessed at baseline and once every 3 months. The rates of treatment discontinuation and time to discontinuation combined with clinical efficacy evaluation were as the outcome measurement. The self-reported adverse events and lab tests were administered to evaluate side effects. Results At the end of the study, 44. 1% patients discontinued their treatment; and 40. 3% patients completed the 1-year follow-up and attained clinical remission. There were no significant differences in the rate of discontinuation and time to discontinuation among the seven groups. There was no significant difference in the total rate of side effects among the seven treatment groups, with significantly different profiles in sedation, extrapyramidal symptoms, weight gain and menstrual irreanlarities. Conclusion The results indicate the clinical effectiveness of 1 year maintenance treatment of the 7 antipsychotic drugs are similar, with some difference in side effect profiles.
作者 房茂胜 赵靖平 国效峰 翟金国 陆铮 孙学礼 王传跃 谢世平 胡斌 郭田生 马崔 汪波 吕路线 刘娜 邓红 陈琦 尚晓芳 龚发金 张喜艳 何小林 周建初 张迎黎 FANG Mao-sheng , ZHAO Jing-ping , GUO Xiao-feng , et aL (Mental Health Institute of the Second Xiangya Hospital, Central South University, Changsha 410011, China)
出处 《中华精神科杂志》 CAS CSCD 北大核心 2009年第1期1-6,共6页 Chinese Journal of Psychiatry
基金 国家“十五”科技攻关计划资助项目(2004BA720A22)
关键词 精神分裂症 抗精神病药 结果评价(卫生保健) 治疗中断率 中断前治疗时间 不良反应 Schizophrenia Antipsychotic agents Outcome assessment (health care) Rate of discontinuation of treatment Time to the discontinuation of treatment Side effects
作者简介 通信作者:赵靖平,Email:zhaojingpinghunan@yahoo.com.cn
  • 相关文献

参考文献14

  • 1Miyamoto S, Duncan GE, Marx CE, et al. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry, 2005, 10: 79-104. 被引量:1
  • 2Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry, 2003, 60 : 553 -564. 被引量:1
  • 3I.eucht S, Wahlbeck K, Hamann J, et al. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet, 2003, 361 : 1581-1589. 被引量:1
  • 4Leucht S, Barnes TR, Kissling W, et al. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry, 2003, 160:1209-1222. 被引量:1
  • 5Thomas P. The stable patient with schizophrenia-from antipsychotic effectiveness to adherence. Eur Neruopsychopharmacol, 2007,17 Suppl 2 : S115-S122. 被引量:1
  • 6Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 2005, 353 : 1209-1223. 被引量:1
  • 7昂秋青,张明园.停药率和停药前用药时间是抗精神病药长期效应的重要评估指标[J].中华精神科杂志,2007,40(1):1-4. 被引量:17
  • 8American Psychiatric Association. Diagnasitc and statistical manual of mental disorders. 4th ed. DSM-IV. Washington : APA, 1994:273-292. 被引量:1
  • 9Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull, 1987, 13:261-267. 被引量:1
  • 10Csemansky JG, Mahmoud R, Brenner R, et al. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med, 2002,346:16-22. 被引量:1

二级参考文献20

  • 1Davis SM, Koch GG, Davis CE, et al. Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies. Schizophr Bull, 2003,29 : 73-80. 被引量:1
  • 2Swartz MS, Perkins DO, Stroup TS, et al. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr Bull, 2003, 29 : 33- 43. 被引量:1
  • 3Jeste DV, Palmer BW, Harris MJ. Neuroleptic discontinuation in clinical and research settings: scientific issues and cthical dilemmas. Biol Psychiatry, 1999, 46: 1050-1059. 被引量:1
  • 4Woerner MG, Robinson DG, Alvir JM, et al. Clozapine as a first treatment for schizophrenia. Am J Psychiatry, 2003, 160: 1514-1516. 被引量:1
  • 5Gibson PJ, Damler R, Jackson EA, et al. The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population. Value Health, 2004, 7: 22-35. 被引量:1
  • 6Rosenheck R, Doyle J, Leslie D, et al. Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugs. Schizophr Bull, 2003, 29: 81-93. 被引量:1
  • 7Stauffer VL, Beasley CM, Liu-Seifert H, et al. Overall treatment effectiveness in schizophrenia-spectrum disorders as measured by time continuing on antipsychotic therapy. Schizophr Bull, 2005,31 : 504-508. 被引量:1
  • 8Kinon B J, Liu-Seifert H, Adams DH, et al. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. J Clin Psychopharmacol, 2006, 26 : 632-637. 被引量:1
  • 9Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 2005, 353: 1209-1223. 被引量:1
  • 10Ascher-Svanum H, Zhu B, Faries D, et al. Time to discontinuation of atypical venus typical antipsychoties in the naturalistic treatment of schizophrenia. BMC Psychiatry, 2006, 6 :8. 被引量:1

共引文献16

同被引文献85

引证文献11

二级引证文献46

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈